Enveric Biosciences ENVB
NASDAQ ENVB
$1.51 +0.07 (+4.86%)
At close: Oct 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) EV to EBITDA (2015 - 2020)

Updated

Enveric Biosciences' (ENVB) EV to EBITDA stood at 2725.21 in Q3 2020, down 26.1% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) EV to EBITDA (2015 - 2020) Analysis & Trends

On a TTM basis, Enveric Biosciences' EV to EBITDA came in at 2724.86 as of Sep 30, 2020.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Enveric Biosciences 6.02 Mn -15.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 2,680.56
Jun 30, 2020 3,686.40
Mar 31, 2020 5,447.63
Sep 30, 2018 155,646.92
Sep 30, 2015 764,383.96
API Access

Enveric Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ENVB&period=max&api_key=YOUR_API_KEY